New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
08:15 EDTACST, NEPTNeptune Technologies, Acasti Pharma, NeuroBio announce resignation of CEO
Neptune Technologies & Bioressources (NEPT), Acasti Pharma (ACST) and NeuroBioPharm jointly announce the resignation of Henri Harland as president and CEO of Neptune, Acasti and NeuroBio with immediate effect. Harland remains a director of Neptune, Acasti and NeuroBio. The businesses will continue to be managed by a management and operations committee under the leadership of Neptune's CFO, André Godin. The search for a new president and CEO will commence immediately.
News For NEPT;ACST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:37 EDTACSTAcasti Pharma granted patent in China
Subscribe for More Information
March 23, 2015
19:10 EDTACST, NEPTNeptune, Acasti announce USPTO decision that triggers royalty payments
Neptune Technologies & Bioressources (NEPT) and Acasti Pharma (ACST) announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office, or USPTO, issued a favorable decision, confirming the validity of certain claims in Neptune's '351 patent and triggering royalty payments to Neptune. "This is a significant milestone that triggers the payment of ongoing royalties to Neptune by Aker and Enzymotec, based on their sales of licensed krill oil products in the US," said Neptuine CEO Jim Hamilton.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use